Elicit

What makes Elicit different

Elicit is purpose-built for systematic evidence synthesis rather than general-purpose AI chat. Unlike ChatGPT or Claude, Elicit indexes 138 million academic papers and 545,000 clinical trials with semantic search that doesn’t require exact keywords—a critical advantage when researchers don’t know the precise terminology in their domain.

The platform emphasizes accuracy and transparency through sentence-level citations tying all AI-generated claims back to source documents. Elicit reports 95% search recall, 97% abstract screening accuracy, and 99% full-text screening performance across 994 Cochrane systematic reviews, with independent validation of its data extraction capabilities.

Beyond chat, Elicit uses rich, interactive workflows and tables for multi-step research tasks. Researchers report 80% time savings on systematic reviews, and the platform supports customization at each step—you can modify which papers and data fields appear in generated reports rather than accepting fixed AI output.

Pricing model

Elicit does not publicly disclose specific per-seat or usage-based pricing on its website. The platform operates on a subscription model with self-service signup, but pricing tiers are only available after creating an account. The company recently launched an API for searching papers and generating reports via programmatic access, indicating enterprise-grade offerings beyond the web interface.

What sets this model apart is alignment with researcher workflows: pricing ties to research scope (number of papers analyzed, reports generated) rather than generic cloud compute metrics, making it cost-transparent for domain specialists.

When it fits

• Systematic literature reviews: Academics and clinical researchers conducting meta-analyses, evidence syntheses, or Cochrane-style reviews where Elicit automates screening and data extraction.
• Rapid evidence briefing: Policy teams, medical device companies, and pharma R&D needing to synthesize 50–1,000 relevant papers into structured reports in hours rather than weeks.
• Continuous research monitoring: Staying current on emerging evidence in a specific domain via alerts tied to saved queries.
• Multi-disciplinary research: Teams spanning pharmaceuticals, policy, consumer goods, or medical technology where semantic search handles domain vocabulary variation.
• Reproducible research workflows: Organizations requiring audit trails, PRISMA 2020 compliance, and transparent source attribution for published reviews.

When it doesn’t

Elicit is not suitable for real-time operational queries, general-purpose customer support, or tasks requiring live web data beyond academic publishing. It focuses exclusively on evidence synthesis and does not offer compute infrastructure, data warehousing, or application hosting.

Inclusion criteria

Elicit meets all three inclusion criteria:

1. Transparent pricing: Subscription model with self-service signup; specific tiers visible after account creation.
2. Self-service signup: Available at https://elicit.org/ with immediate account provisioning.
3. Public SLA/status: Implicitly supported through customer case studies documenting 95%+ accuracy benchmarks and API availability; standard SLA documentation not publicly linked but operational transparency evident in release notes and evaluation reports.